William S. Reardon, Director at SYNTA PHARMACEUTICALS CORP (SNTA), bought 13,333 shares at $3.75 ($50K) on 2013-11-13, disclosed to the SEC on 2013-11-15.
Open-market purchase of $50k SNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HQL | BUY | 2014-07-01 | $4K | — | Filing → |
| IDRA | BUY | 2013-09-17 | $25K | — | Filing → |
| HQL | BUY | 2012-03-12 | $10K | — | Filing → |